Multiple Sclerosis (MS)
73
14
18
31
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.2%
6 terminated out of 73 trials
83.8%
-2.8% vs benchmark
8%
6 trials in Phase 3/4
32%
10 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 31 completed trials
Clinical Trials (73)
A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis
Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
Effect of Music Therapy on Pain in People With Multiple Sclerosis
Vista Protein Expression of Monocyte and T Cell Subsets in Multiple Sclerosis and Its Clinical Correlation
An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden
Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases
TELESM-edu.Nursing: a Personalised Nursing Intervention for People With Multiple Sclerosis
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
My MS Toolkit: An Internet-Based Depression Self-Management Program for Adults Living With Multiple Sclerosis
MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis
Essential Oils for Urinary Symptoms in Multiple Sclerosis Patients
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France
A Palliative Care Model Impact on Knowledge and Attitudes
A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.
Prevalence of Periodontitis in Egyptian Multiple Sclerosis Patients.